Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 26
Filter
1.
Braz. j. microbiol ; 46(3): 777-783, July-Sept. 2015. tab, ilus
Article in English | LILACS | ID: lil-755813

ABSTRACT

Vancomycin resistant Enterococcus faecium (VREF) ia an emerging and challenging nosocomial pathogen. This study aimed to determine the prevalence, risk factors and clonal relationships between different VREF isolates in the intensive care units (ICUs) of the university hospitals in our geographic location. This prospective study was conducted from July, 2012 until September, 2013 on 781 patients who were admitted to the ICUs of the Mansoura University Hospitals (MUHs), and fulfilled the healthcare-associated infection (HAI) criteria. Susceptibility testing was determined using the disk diffusion method. The clonal relationships were evaluated with pulsed field gel electrophoresis (PFGE). Out of 52 E. faecium isolates, 12 (23.1%) were vancomycin resistant. The significant risk factors for the VREF infections were: transfer to the ICU from a ward, renal failure, an extended ICU stay and use of third-generation cephalosporins, gentamicin, or ciprofloxacin. PFGE with the 12 isolates showed 9 different patterns; 3 belonged to the same pulsotype and another 2 carried a second pulsotypes. The similar pulsotypes isolates were isolated from ICUs of one hospital (EICUs); however, all of the isolates from the other ICUs had different patterns. Infection control policy, in conjunction with antibiotic stewardship, is important to combat VREF transmission in these high-risk patients.

.


Subject(s)
Humans , Anti-Bacterial Agents/therapeutic use , Cross Infection/epidemiology , Enterococcus faecium/drug effects , Gram-Positive Bacterial Infections/epidemiology , Vancomycin Resistance/physiology , Vancomycin-Resistant Enterococci/isolation & purification , Vancomycin/therapeutic use , Cephalosporins/therapeutic use , Ciprofloxacin/therapeutic use , Cross Infection/microbiology , DNA, Bacterial/genetics , Egypt/epidemiology , Enterococcus faecium/isolation & purification , Gentamicins/therapeutic use , Gram-Positive Bacterial Infections/drug therapy , Gram-Positive Bacterial Infections/microbiology , Intensive Care Units , Infection Control/methods , Microbial Sensitivity Tests , Prospective Studies , Renal Insufficiency , Risk Factors , Vancomycin-Resistant Enterococci/drug effects
2.
Ciênc. Saúde Colet. (Impr.) ; 20(7): 2211-2220, 07/2015.
Article in Portuguese | LILACS | ID: lil-749930

ABSTRACT

Resumo Este artigo pretende compreender a visão das pacientes com câncer sobre o processo de adoecimento e os procedimentos terapêuticos que experimentam. Os tratamentos de câncer provocam uma série de consequências físicas e emocionais nas pacientes, assim, estas passam por uma reestruturação e elaboram mecanismos para “cuidarem de si”. A metodologia utilizada foi a etnográfica, desencadeada por meio de entrevistas, anotações em diário de campo e observação participante. A etnografia revelou como essas mulheres, submetidas ao tratamento convencional em determinado hospital, criam tecnologias de cuidado compartilhadas baseadas na sociabilidade.


Abstract This article seeks to understand the viewpoint of cancer patients about the disease process and the therapeutic procedures that they experience. Cancer treatments provoke a series of physical and emotional consequences in patients. Thus, patients undergo a restructuring of life and establish mechanisms to “take care of themselves.” The methodology used was an ethnographic approach through interviews, field notes and participant observation. The ethnographic approach revealed how these women being given conventional treatment in a given hospital create shared care technologies based on sociability.


Subject(s)
Humans , Infant, Newborn , Cross Infection/epidemiology , Disease Outbreaks , Enterococcus faecium/drug effects , Gram-Positive Bacterial Infections/epidemiology , Intensive Care Units, Neonatal , Vancomycin Resistance , Bacterial Typing Techniques , Cross Infection/microbiology , Cross Infection/prevention & control , Enterococcus faecium/isolation & purification , Gram-Positive Bacterial Infections/prevention & control , Infection Control/methods
3.
Braz. j. microbiol ; 46(1): 237-249, 05/2015. tab, graf
Article in English | LILACS | ID: lil-748255

ABSTRACT

This study aimed to characterize the safety and technological properties of Enterococcus faecium strains isolated from Brazilian Coalho cheeses. High levels of co-aggregation were observed between Enterococcus faecium strains EM485 and EM925 and both Escherichia coli and Clostridium perfringens. Both strains presented low levels of hydrophobicity. E. faecium EM485 and EM925 were both able to grow in the presence of 0.5% of the sodium salts of taurocholic acid (TC), taurodeoxycholic acid (TDC), glycocholic acid (GC), and glycodeoxycholic acid (GDC), although they showed the ability to deconjugate only GDC and TDC. Both strains showed good survival when exposed to conditions simulating the gastro intestinal tract (GIT). When tested for the presence of virulence genes, only tyrosine decarboxylase and vancomycin B generated positive PCR results.


Subject(s)
Cheese/microbiology , Enterococcus faecium/isolation & purification , Enterococcus faecium/physiology , Food Safety , Food Handling/methods , Bacterial Adhesion , Brazil , Chemical Phenomena , Cholic Acids/metabolism , Cholic Acids/toxicity , Clostridium perfringens/chemistry , Clostridium perfringens/physiology , Enterococcus faecium/chemistry , Escherichia coli/chemistry , Escherichia coli/physiology , Gastrointestinal Tract/chemistry , Hydrophobic and Hydrophilic Interactions , Inactivation, Metabolic , Microbial Viability/drug effects , Polymerase Chain Reaction , Virulence Factors/analysis , Virulence Factors/genetics
5.
Arq. bras. med. vet. zootec ; 66(3): 940-948, 06/2014. tab
Article in English | LILACS | ID: lil-718096

ABSTRACT

Lactic acid bacteria species were molecularly identified in milk from Lacaune, Santa Inês and crossbred sheep breeds and their in vitro probiotic potential was evaluated. The species identified were Enterococcus faecium (56.25%), E. durans (31.25%) and E. casseliflavus (12.5%). No other lactic acid bacteria species, such as lactobacilli, was identified. Most of the isolated enterococci were resistant to gastric pH (2.0) and to 0.3% oxgall. All tested enterococci were resistant to ceftazidime, oxacillin and streptomycin and sensible to clindamycin, erythromycin and penicillin. The resistance to ciprofloxacin, gentamicin, tetracycline and vancomycin varied among tested species. All tested enterococci strongly inhibited (P<0.05) Escherichia coli and Listeria monocytogenes, moderately inhibited E. faecalis and Staphylococcus aureus and did not inhibit Pseudomonas aeruginosa, Salmonella enterica var. Typhimurium and also one E. durans sample isolated from sheep milk. Four samples of E. faecium, one of E. durans and one of E. casseliflavus presented the best probiotic potential...


Espécies de bactérias ácido-lácticas foram identificadas em nível molecular em leite das raças ovinas Lacaune, Santa Inês e suas mestiças, e o seu potencial probiótico in vitro foi avaliado. As espécies identificadas foram Enterococcus faecium (56,25%), E. durans (31,25%) e E. casseliflavus (12,5%). Nenhuma outra espécie de bactéria ácido-láctica, como Lactobacillus sp., foi identificada. A maioria dos enterococos isolados foi resistente ao pH gástrico (2.0) e a 0,3% de oxgall. Todos os enterococos testados foram resistentes à ceftazidima, oxacilina e estreptomicina e sensíveis à clindamicina, eritromicina e penicilina. A resistência à ciprofloxacina, gentamicina, tetraciclina e vancomicina variou entre as amostras. Todos os enterococos testados inibiram fortemente (P<0,05) Escherichia coli e Listeria monocytogenes, inibiram moderadamente E. faecalis e Staphylococcus aureus e não inibiram Pseudomonas aeruginosa, Salmonella enterica var. Typhimurium e uma amostra de E. durans isolada de leite de ovelha. Quatro amostras de E. faecium, uma de E. durans e uma de E. casseliflavus apresentaram o melhor potencial probiótico...


Subject(s)
Animals , Female , Lactic Acid/analysis , Ceftazidime/isolation & purification , Enterococcus faecium/isolation & purification , Enterococcus/isolation & purification , Streptomycin/isolation & purification , Sheep/microbiology , Oxacillin/isolation & purification , Drug Resistance , Drug Resistance, Multiple, Bacterial
6.
Biomédica (Bogotá) ; 34(supl.1): 50-57, abr. 2014. graf, tab
Article in Spanish | LILACS | ID: lil-712421

ABSTRACT

Introducción. Actualmente se considera a Enterococcus spp. como uno de los agentes de infección hospitalaria más importantes, siendo su resistencia a los antibióticos un problema importante en los centros de salud. Objetivos. Caracterizar la resistencia antimicrobiana en 50 cepas de Enterococcus spp. aisladas de muestras clínicas de pacientes hospitalizados . Materiales y métodos. Se llevó a cabo un estudio de tipo descriptivo observacional de corte transversal en 50 aislamientos clínicos de estas especies microbianas. Se trabajó un aislamiento por paciente. La identificación y la sensibilidad a los antibióticos se realizaron por métodos automatizados y convencionales. El análisis fenotípico de los mecanismos de resistencia a glucopéptidos se hizo según las recomendaciones de la Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. Resultados. De 50 aislamientos, 30 (60,0 %) y 20 (40,0 %) pertenecían a las especies de Enterococcus faecalis y Enterococcus faecium, respectivamente. La resistencia global expresada por este género fue de 38/50 (76,0 %) para ampicilina; 33/50 (66,0 %) para gentamicina de alto nivel; 34/50 (68,0 %) para estreptomicina de alto nivel; 26/50 (52,0 %) para ciprofloxacina; 4/50 (8,0 %) para linezolid; 17/50 (34,0 %) para teicoplanina; 25/50 (50,0 %) para vancomicina; 31/50 (62,0 %) para minociclina; 34/50 (68,0 %) para tetraciclina y 9/50 (18,0 %) para nitrofurantoina. Frente a los glucopéptidos, 25/50 (50,0 %) y 10/50 (20,0 %) de los aislamientos presentaron los mecanismos Van A y Van B, respectivamente. Conclusiones. Podemos concluir que la mayoría de las veces, las cepas aisladas en el Hospital Hermanos Ameijeiras mostraron porcentajes de resistencia por encima de lo reportado en la literatura científica consultada. El alto porcentaje de cepas con resistencia a la vancomicina podría influir en la aparición de otros gérmenes Gram positivos con resistencia a este fármaco. Se reporta por primera vez en un hospital cubano resistencia de E. faecium a linezolid.


Introduction: Enterococcus spp is currently considered as one of the most important nosocomial pathogens . The antibiotic resistance of this group of bacteria is a particularly important problem in health centers. Objective: To characterize the antibiotic resistance of 50 Enterococcus spp strains isolated from hospitalized patients clinical samples. Materials and methods: We conducted a cross-sectional descriptive observational study in 50 clinical isolates of Enterococcus spp. Only one isolate per patient was analyzed . The identification and antibiotic susceptibility were studied by conventional and automated methods . The phenotypic analysis of glycopeptide resistance mechanisms was performed as recommended by the Spanish Society of Clinical Microbiology and Infectious Diseases . Results: Of 50 isolates obtained from clinical samples, 30 ( 60.0%) belonged to Enterococcus faecalis and 20 (40.0 %) to Enterococcus faecium . The global resistance expressed by this genre was as follows: Ampicillin, 38/50 ( 76.0%); high-level gentamicin, 33/50 ( 66.0%); high-level streptomycin, 34/50 (68.0 %) ; ciprofloxacin, 26/50 (52.0 %); linezolid, 4/50 (8.0 %); teicoplanin, 17/50 ( 34.0%); vancomycin, 25/50 (50.0 %); minocycline, 31/50 ( 62.0%); tetracycline, 34/50 (68.0 %); nitrofurantoin, 9/50 ( 18.0%). As regards glycopeptides, 25/50 (50.0%) showed a Van A mechanism and 10/50 (20.0 %) a Van B mechanism . Conclusions: The isolates obtained at Hospital Hermanos Ameijeiras showed higher resistance rates than those reported in the consulted literature. The high percentage of vancomycin-resistant strains might have influenced the development of other Gram-positive bacteria resistant to this drug. This is the first report on Enterococcus faecium resistant to linezolid in a Cuban hospital.


Subject(s)
Humans , Cross Infection/microbiology , Drug Resistance, Multiple, Bacterial , Enterococcus faecalis/drug effects , Enterococcus faecium/drug effects , Gram-Positive Bacterial Infections/microbiology , Acetamides/pharmacology , Bacterial Typing Techniques , Cross Infection/epidemiology , Cuba/epidemiology , Enterococcus faecalis/isolation & purification , Enterococcus faecium/isolation & purification , Gram-Positive Bacterial Infections/epidemiology , Hospitals, Urban/statistics & numerical data , Microbial Sensitivity Tests , Oxazolidinones/pharmacology , Tertiary Care Centers/statistics & numerical data , Vancomycin Resistance
7.
Rev. Inst. Med. Trop. Säo Paulo ; 56(1): 77-80, Jan-Feb/2014. graf
Article in English | LILACS | ID: lil-702057

ABSTRACT

Enterococci are Gram-positive cocci saprophyte of the human gastrointestinal tract, diners who act as opportunistic pathogens. They can cause infections in patients hospitalized for a long time or who have received multiple antibiotic therapy. Enterococcus faecalis and Enterococcus faecium are the most common species in human infections. To evaluate the possibility of rapid detection of these species and their occurrence in the blood of newborns with suspected nosocomial infection, blood samples were collected from 50 newborns with late infections, admitted to the Neonatal Care Unit of the University Hospital Federal de Mato Grosso do Sul (UFMS-HU), from September 2010 to January 2011. The samples were subjected to conventional PCR and real time PCR (qPCR) to search for Enterococcus faecium and Enterococcus faecalis, respectively. The PCR results were compared with respective blood cultures from 40 patients. No blood cultures were positive for Enterococci, however, eight blood samples were identified as genomic DNA of Enterococcus faecium by qPCR and 22 blood samples were detected as genomic DNA of Enterococcus faecalis by conventional PCR. These findings are important because of the clinical severity of the evaluated patients who were found positive by conventional PCR and not through routine microbiological methods.


Os enterococos são cocos Gram-positivos saprófitas do trato gastrointestinal humano, atuam como patógenos oportunistas. Podem causar infecções em pacientes: hospitalizados por um longo tempo ou que receberam antibioticoterapia múltipla. Enterococcus faecalis e Enterococcus faecium são as espécies mais comuns em infecções humanas. Para avaliar a possibilidade de detecção rápida dessas espécies e sua ocorrência no sangue de recém-nascidos com suspeita de infecção hospitalar, foram coletadas amostras de sangue de 50 recém-nascidos, com infecção tardia, internados na Unidade de Terapia Neonatal do Hospital Universitário da Universidade Federal de Mato Grosso do Sul (UFMS-HU), no período de setembro de 2010 a janeiro de 2011. As amostras foram submetidas a PCR convencional e PCR em tempo real (qPCR) para pesquisa de Enterococcus faecium e Enterococcus faecalis, respectivamente. Os resultados da PCR foram comparados com culturas de sangue respectivos de 40. Nenhuma hemocultura foi positiva para enterococos, no entanto, em oito amostras de sangue foi identificado DNA genômico de Enterococcus faecium através da técnica de reação em cadeia da polimerase em tempo real, e em 22 amostras de sangue, foram detectados DNA genômico de Enterococcus faecalis, através de PCR convencional. A descoberta é importante por causa da gravidade clínica dos pacientes avaliados que foram positivos por PCR convencional e não foram detectados na rotina por métodos microbiológicos.


Subject(s)
Female , Humans , Infant, Newborn , Male , Cross Infection/diagnosis , Enterococcus faecalis/genetics , Enterococcus faecium/genetics , Gram-Positive Bacterial Infections/diagnosis , Bacterial Typing Techniques , Cross Infection/microbiology , DNA, Bacterial/genetics , Enterococcus faecalis/isolation & purification , Enterococcus faecium/isolation & purification , Gram-Positive Bacterial Infections/microbiology , Intensive Care Units, Neonatal , Polymerase Chain Reaction/methods , Sensitivity and Specificity
8.
Pesqui. vet. bras ; 33(5): 575-580, maio 2013. ilus, tab
Article in Portuguese | LILACS | ID: lil-678334

ABSTRACT

O objetivo deste trabalho foi realizar o isolamento e analisar o perfil de resistência antimicrobiana de Enterococcus de carcaças de frango resfriadas e congeladas comercializadas no Distrito Federal, detectando genes de resistência antimicrobiana e identificando as espécies Enterococcus faecalis e Enterococcus faecium por reação polimerase em cadeia. Foram analisadas 100 carcaças de frangos, das quais foram isoladas 50 cepas de Enterococcus spp., sendo 42% de E. faecalis e 2% de E. faecium. O teste de susceptibilidade antimicrobiana demonstrou que todas as cepas isoladas apresentaram resistência a pelo menos um antimicrobiano, dos quais 90,47% das cepas de E. faecalis, 100% das cepas de E. Faecium e 82,14% dos Enterococcus spp. apresentaram resistência à Tetraciclina; 80,95% das cepas de E. faecalis e 35,71% das cepas de Enterococcus spp. foram resistentes à Eritromicina; 39,28% dos Enterococcus spp. e 23,80% dos E. faecalis à Ciprofloxacina e 28,57% dos E. faecalis apresentaram resistência ao Cloranfenicol. Foram detectados os genes de resistência antimicrobiana erm(B), vanC-1, aph(3')-llla, ant(6)-la, vanB, vanA, aac(6')-le-aph(2'')-la, erm(A) e tet(M) - este último mais frequente. Estes resultados sugerem sérios problemas para a Saúde Pública, uma vez que esses microrganismos podem possuir a capacidade de transmitir genes de resistência antimicrobiana para outros microrganismos presentes na microbiota intestinal de humanos e animais, podendo inviabilizar o uso destas drogas para tratamentos clínicos.


The aim of this study was to isolate and analyze the antimicrobial profile resistance of Enterococcus from cooled and frozen poultry carcasses commercialized at the Federal District area, detecting the antimicrobial resistance genes and identifying Enterococcus faecalis and Enterococcus faecium by polymerase chain reaction. One hundred poultry carcasses were analyzed and 50 strains of Enterococcus spp. were isolated, of which 42% were E. faecalis and 2% E. faecium. The antimicrobial susceptibility test showed that all isolates were resistant to at least one antibiotic; 90,47% of E. faecalis, 100% of E. faecium and 82,14% of Enterococcus spp. were resistant to Tetracycline; 80,95% of E. faecalis and 35,71% of Enterococcus spp. strains were resistant to Erythromycin; 39,28% of Enterococcus spp. and 23,80% of E. faecalis to Ciprofloxacin, and 28,57% of E. faecalis were resistant to Chloramphenicol. There were detected erm(B), vanC-1, aph(3')-llla, ant(6)-la, vanB, vanA, aac(6')-le-aph(2'')-la, erm(A) and tet(M) resistance genes, the last one most often verified. The results might suggest problems for public health due the high resistance, since these microorganisms have ability to transmit genes for antimicrobial resistance to others in the intestinal tract of humans and animals. Thus, the use of these drugs for clinical treatment could be hindered.


Subject(s)
Animals , Frozen Foods/microbiology , Drug Resistance, Microbial , Enterococcus faecalis/isolation & purification , Enterococcus faecium/isolation & purification , Chickens/microbiology , Chloramphenicol Resistance , Tetracycline Resistance
10.
The Korean Journal of Gastroenterology ; : 330-334, 2012.
Article in Korean | WPRIM | ID: wpr-11953

ABSTRACT

Strongyloides stercoralis is a soil transmitted intestinal nematode that is endemic in the tropical and subtropical regions. In most individuals who are infected, chronic, usually asymptomatic, gastrointestinal infection persists. But, in immunocompromized hosts or in patients receiving immunosuppressive therapy, autoinfection of S. stercoralis may result in the dissemination of larvae, leading to fatal hyperinfection and increased rate of complications. We report a case of hyperinfective strongyloidiasis with bacterial meningitis in a patient receiving steroid therapy. Strongyloidiasis was diagnosed by the presence of filariform larvae of S. stercoralis in the bronchoalveolar lavage cytology and upper gastrointestinal endoscopic biopsy specimen. Her clinical symptoms had progressively aggravated and developed bacterial meningitis during treatment. She died despite aggressive antibiotic and antihelminthic therapy.


Subject(s)
Aged , Animals , Female , Humans , Adrenal Insufficiency/drug therapy , Bronchoalveolar Lavage Fluid/parasitology , Endoscopy, Gastrointestinal , Enterococcus faecium/isolation & purification , Immunocompromised Host , Intestinal Mucosa/pathology , Larva/physiology , Magnetic Resonance Imaging , Meningitis, Bacterial/complications , Steroids/adverse effects , Strongyloides stercoralis/growth & development , Strongyloidiasis/complications
11.
Article in Spanish | LILACS | ID: lil-612948

ABSTRACT

Objective. To identify infection-causing Enterococcus species in Cuban hospitalsand determine their susceptibility to antimicrobial drugs, as well as their resistance mechanisms. Methods. A total of 687 Enterococcus isolates from 30 Cuban hospitals in nine provinces of the country were studied over the period 2000–2009. The species were identified using both the conventional method and the automatic API® system.The minimum inhibitory concentration was determined for 13 antimicrobial drugs following the standards recommended by the Clinical Laboratory and Standards Institute. The polymerase chain reaction technique was used to characterize the genes that were resistant to aminoglycosides, erythromycin, tetracycline, andglucopeptides. The presence of beta-lactamase was determined by the chromogenic cephalosporin test. Results. The most prevalent species were Enterococcus faecalis (82.9%) and E. faecium (12.2%). Resistance to glucopeptides (1.0%) was mediated by the vanA and vanB genes. The strains resistant to ampicillin (6%) did not produce beta-lactamases. A high percentage of resistance to aminoglycosides was observed. Gentamicin (31.0%) and streptomycin and amikacin (29.1%) were mediated by the aac(6’)Ie-aph(2”)Ia, aph(3’)-IIIa, ant(6)Ia, and ant(3”)(9) genes. A correlation was found between resistance to tetracycline (56.0%) and presence of the tet(M) (75.1%) and tet(L) genes (7.0%), while resistance to erythromycin (34.1%) was due to the erm(B) gene (70.9%). Conclusions. Resistance to vancomycin is infrequent in Cuba, as opposed to a high level of resistance to aminoglycosides, which may be indicative of treatment failures. The microbiology laboratory is a cornerstone of Enterococcus infectionsurveillance, along with ongoing monitoring of the susceptibility of these infections to antimicrobial drugs at a time when resistance of this microorganism is on the rise.


Objetivo. Identificar las especies de Enterococcus causantes de infecciones en hospitales cubanos, su susceptibilidad a los antimicrobianos y sus mecanismos de resistencia.Métodos. Se estudiaron 687 aislamientos de Enterococcus procedentes de 30 hospitalescubanos de nueve provincias del país durante el período de 2000 a 2009. La identificación de las especies se realizó mediante el método convencional y sistema automatizado API®. Laconcentración inhibitoria mínima se determinó para 13 antimicrobianos según las recomendaciones del Instituto de Estándares Clínicos y de Laboratorio. Se determinaron los genes de resistencia a aminoglucósidos, eritromicina, tetraciclina y glucopéptidos mediante reacciónen cadena de la polimerasa. La presencia de betalactamasa se determinó por el método de lacefalosporina cromógena. Resultados. Las especies más prevalentes fueron Enterococcus faecalis (82,9%) y Enterococcus faecium (12,2%). La resistencia a los glucopéptidos (1,0%) estuvo mediada por los genes vanA y vanB y las cepas resistentes a ampicilina (6%) no produjeron betalactamasas. Se observó un alto porcentaje de resistencia a los aminoglucósidos: gentamicina (31,0%) y estreptomicina y amikacina (29,1%) mediada por los genes aac(6’)Ie-aph(2”)Ia, aph(3’)-IIIa, ant(6)Ia, ant(3”)(9). Hubo correlación entre la resistencia a tetraciclina (56,0%) y la presencia de los genes tet(M) (75,1%) y tet(L) (7,0%), mientras que la resistencia a eritromicina (34,1%) obedeció al gen erm(B) (70,9%).Conclusiones. La resistencia a vancomicina es infrecuente en Cuba, a diferencia del alto nivel de resistencia a los aminoglucósidos, que sugiere posibles fracasos terapéuticos. El laboratorio de microbiología constituye un pilar fundamental de la vigilancia de las infecciones por cepas de Enterococcus y el monitoreo continuo de su susceptibilidad a los antimicrobianos,dado el incremento de la resistencia de ese microorganismo en el tiempo.


Subject(s)
Humans , Drug Resistance, Microbial , Enterococcus/genetics , Gram-Positive Bacterial Infections/microbiology , Aminoglycosides/pharmacology , Cross Infection/epidemiology , Cross Infection/microbiology , Cuba , Drug Resistance, Microbial/genetics , Drug Resistance, Multiple, Bacterial , Enterococcus faecalis/enzymology , Enterococcus faecalis/genetics , Enterococcus faecalis/isolation & purification , Enterococcus faecium/enzymology , Enterococcus faecium/genetics , Enterococcus faecium/isolation & purification , Enterococcus/enzymology , Enterococcus/isolation & purification , Genes, Bacterial , Gram-Positive Bacterial Infections/epidemiology , Species Specificity , Vancomycin Resistance/genetics
12.
Braz. j. microbiol ; 42(3): 1238-1247, July-Sept. 2011. ilus, tab
Article in English | LILACS | ID: lil-607560

ABSTRACT

The aim of this study was to investigate whether the ingestion of soy yogurt fermented with Enterococcus faecium CRL 183 would modify the intestinal count of enterococci, fecal pH and ammonia content in rats fed on a diet containing red meat. The rats were placed in 4 groups: for 60 days, group I was given a standard casein-based rodent feed and groups II-IV, the beef-based feed. From day 30, groups III-IV also received the following products: III) soy yogurt; IV) suspension of E. faecium CRL 183. At the start and on days 30 and 60, feces were collected for the determination of pH, ammonia content, count of enterococci and identification of their species. On day 60, rats were sacrificed and their colons also removed for count of enterococci and identification of their species. Rats that ingested soy yogurt showed no significant change (P<0.05) in fecal counts of Enterococcus spp., but, this rat group showed a higher count of E. faecium than rats that ingested suspension of E. faecium CRL 183. The ingestion of soy yogurt and E. faecium culture caused a significant rise (P < 0.05) in fecal pH and ammonia content. Our results suggest that consumption of soy yogurt fermented with E. faecium CRL 183 and L. helveticus subsp. jugurti could change the species of Enterococcus spp. present in the feces and colon of rats fed on a beef-based diet. However, the fermented soy product and the pure culture of E. faecium CRL 183 also induced undesirable effects such as the increase of fecal pH and ammonia content in the feces of rats fed on a beef-based diet.


Subject(s)
Mice , Ammonia/analysis , Diet , Enterococcus faecium/isolation & purification , Enterococcus/isolation & purification , Fermentation , Food Microbiology , Yogurt/analysis , Soybeans , Feces , Food Samples , Methods , Microbiology , Methods
14.
Braz. j. med. biol. res ; 44(3): 253-257, Mar. 2011. ilus, tab
Article in English | LILACS | ID: lil-576072

ABSTRACT

In this study, we report the characterization of a strain of Enterococcus faecium vanA, which grows only in the presence of vancomycin (VDEfm-UEL). The bacterium was isolated from the feces of a female patient who had undergone surgical treatment of Reinke’s edema and was receiving intravenous vancomycin therapy for infection with methicillin/oxacillin-resistant Staphylococcus aureus, a postoperative complication. Antimicrobial dependence was further confirmed by the vancomycin E-test. VDEfm-UEL was also shown to be resistant to ampicillin, ciprofloxacin, chloramphenicol, erythromycin, levofloxacin, penicillin, rifampicin, and teicoplanin. The putative virulence genes efaA, gelE and esp were detected by PCR. The ddl gene from VDEfm-UEL was cloned and sequenced. Vancomycin dependence seems to be associated with the insertion of a nucleotide in that sequence, which results in a frame-shift mutation, introducing a premature stop codon. This is the first report of vancomycin-dependent E. faecium isolation in a university hospital in Brazil.


Subject(s)
Aged , Female , Humans , Anti-Bacterial Agents/pharmacology , Enterococcus faecium/drug effects , Vancomycin Resistance/genetics , Cross Infection/microbiology , Drug Resistance, Multiple, Bacterial/drug effects , Enterococcus faecium/genetics , Enterococcus faecium/isolation & purification , Feces/microbiology , Frameshift Mutation/genetics , Hospitals, University , Microbial Sensitivity Tests , Methicillin-Resistant Staphylococcus aureus/drug effects , Polymerase Chain Reaction
15.
Indian J Pathol Microbiol ; 2011 Jan-Mar 54(1): 90-95
Article in English | IMSEAR | ID: sea-141923

ABSTRACT

Introduction: While foot infections in persons with diabetes are initially treated empirically, therapy directed at known causative organisms may improve the outcome. Many studies have reported on the bacteriology of diabetic foot infections (DFIs), but the results have varied and have often been contradictory. The purpose of the research work is to call attention to a frightening twist in the antibiotic-resistant Enterococci problem in diabetic foot that has not received adequate attention from the medical fraternity and also the pharmaceutical pipeline for new antibiotics is drying up. Materials and Methods: Adult diabetic patients admitted for lower extremity infections from July 2008 to December 2009 in the medical wards and intensive care unit of medical teaching hospitals were included in the study. The extent of the lower extremity infection on admission was assessed based on Wagner's classification from grades I to V. Specimens were collected from the lesions upon admission prior to the initiation of antibiotic therapy or within the first 48 h of admission. Results: During the 18-month prospective study, 32 strains of Enterococcus spp. (26 Enterococcus faecalis and 06 E. faecium) were recovered. Antibiotic sensitivity testing was done by Kirby-Bauer's disk diffusion method. Isolates were screened for high-level aminoglycoside resistance (HLAR). A total of 65.6% of Enterococcus species showed HLAR. Multidrug resistance and concomitant resistance of HLAR strains to other antibiotics were quite high. None of the Enterococcus species was resistant to vancomycin. Conclusion: Multidrug-resistant Enterococci are a real problem and continuous surveillance is necessary. Today, resistance has rendered most of the original antibiotics obsolete for many infections, mandating the development of alternative anti-infection modalities. One of such alternatives stemming up from an old idea is the bacteriophage therapy. In the present study, we could able to demonstrate the viable phages against MDR E. faecalis.


Subject(s)
Adult , Aged , Aged, 80 and over , Anti-Infective Agents/pharmacology , Bacteriophages/growth & development , Biological Therapy/methods , Diabetic Foot/microbiology , Drug Resistance, Multiple, Bacterial , Enterococcus faecalis/drug effects , Enterococcus faecalis/isolation & purification , Enterococcus faecium/drug effects , Enterococcus faecium/isolation & purification , Female , Gram-Positive Bacterial Infections/epidemiology , Gram-Positive Bacterial Infections/microbiology , Humans , Male , Prevalence , Prospective Studies
16.
Braz. j. microbiol ; 41(1): 74-81, Jan.-Mar. 2010. graf, tab
Article in English | LILACS | ID: lil-531737

ABSTRACT

This study investigated the antimicrobial activity of Enterococcus faecium FAIR-E 198 against Bacillus cereus, Listeria monocytogenes and Staphylococcus aureus. Using the critical-dilution method, the bacteriocin produced by E. faecium FAIR-E 198 inhibited all L. monocytogenes strains evaluated (1,600 to 19,200 AU mL-1). However, none of the B. cereus and S. aureus strains investigated were inhibited. The maximum activity of this bacteriocin (800 AU mL-1) was observed in MRS broth, while the activity in milk was 100 AU mL-1. In the co-cultivation test in milk, B. cereus K1-B041 was reduced to below the detection limit (1.00 log CFU mL-1) after 48 h. E. faecium reduced the initial L. monocytogenes Scott A population by 1 log CFU mL-1 after 3 h at 35ºC. However, the pathogen regained growth, reaching 3.68 log CFU mL-1 after 48 h. E. faecium did not influence the growth of S. aureus ATCC 27154 during the 48 h of co-cultivation. Therefore, it can be concluded that the effectiveness of the antimicrobial activity of E. faecium FAIR-E 198 is strictly related to the species and strain of the target microorganism and to the culture medium.


Subject(s)
Bacteriocins/analysis , Bacteriocins/isolation & purification , Food Contamination/analysis , Enterococcus faecium/isolation & purification , Dairy Products/analysis , Food Samples , Methods , Methods , Virulence
18.
Mem. Inst. Oswaldo Cruz ; 103(3): 301-305, May 2008. ilus, tab
Article in English | LILACS | ID: lil-485225

ABSTRACT

Three Enterococcus faecalis and one Enterococcus faecium strains were characterized by plasmid profile, pulsed-field gel electrophoresis (PFGE) and determination of antimicrobial minimal inhibitory concentrations. VanA elements were characterized by Long PCR, overlapping PCR and DNA sequencing. Enterococcal strains showed resistance to vancomycin and harbored the vanA gene, and three these were teicoplanin susceptible while one showed intermediate resistance to teicoplanin. Two E. faecalis strains showed indistinguishable PFGE profile while the third was unrelated. E. faecalis strains showed a deletion in the right terminal region of the Tn1546-like element. The E. faecium strain showed an insertion element in the vanXY intergenic region. Mutations in VanA elements were not found. Rearrangements in the VanA element could be responsible for incongruities in genotype and phenotype in these strains.


Subject(s)
Humans , Anti-Bacterial Agents/pharmacology , Enterococcus faecalis , Enterococcus faecium , Teicoplanin/pharmacology , Vancomycin/pharmacology , Brazil , Bacterial Proteins/genetics , Carbon-Oxygen Ligases/genetics , DNA, Bacterial/genetics , Electrophoresis, Gel, Pulsed-Field , Enterococcus faecalis/drug effects , Enterococcus faecalis/genetics , Enterococcus faecalis/isolation & purification , Enterococcus faecium/drug effects , Enterococcus faecium/genetics , Enterococcus faecium/isolation & purification , Genotype , Microbial Sensitivity Tests , Phenotype , Polymerase Chain Reaction , Sequence Analysis, DNA , Vancomycin Resistance/genetics
19.
Salud pública Méx ; 49(5): 330-336, sep.-oct. 2007. graf, tab
Article in Spanish | LILACS | ID: lil-465593

ABSTRACT

OBJETIVOS: Describir los patrones de resistencia bacteriana en cultivos de orina en un hospital oncológico. MATERIAL Y MÉTODOS: Se incluyeron las cepas obtenidas de cultivos de orina de 1998 a 2005. Se obtuvo el porcentaje de sensibilidad para diferentes antibióticos, tras analizar por separado cepas nosocomiales y compararlas con las de la comunidad. RESULTADOS: Se detectaron 9 232 cultivos positivos (20.7 por ciento) de 44 447 muestras: gramnegativos, 78.8 por ciento; grampositivos, 13.8 por ciento; y levaduras, 7.4 por ciento. Escherichia coli fue el principal microorganismo identificado (41.3 por ciento); la resistencia en aislados nosocomiales fue mayor que en la comunidad para amikacina (92.4 y 97 por ciento), ceftazidima (83.1 y 95.1 por ciento) y ciprofloxacina (46.2 y 58.6 por ciento). De igual manera, Pseudomonas aeruginosa presentó mayor resistencia para amikacina y ceftazidima en las cepas nosocomiales (55.7 y 66.6 por ciento; y 65.5 y 84.8 por ciento, respectivamente). Enterococcus resistente a vancomicina se encontró sólo en 2.5 por ciento (3/119 aislados de E. faecium). CONCLUSIONES: Existe una mayor resistencia bacteriana en las cepas de origen nosocomial en comparación con las cepas comunitarias. Se encontró un incremento progresivo de la resistencia para E. coli, el patógeno aislado con más frecuencia de infecciones nosocomiales y comunitarias. Es prioritario intensificar una campaña educativa para el control y uso racional de los antibióticos.


OBJECTIVE: To describe the patterns of antimicrobial resistance of organisms isolated from urine cultures at a teaching oncological hospital for adult patients. MATERIAL AND METHODS: All strains obtained from urine cultures from 1998 to 2005 were included. Mean susceptibilities were obtained for each antimicrobial tested; nosocomial and community-acquired isolates were analyzed separately. RESULTS: A total of 9 232 positive urine cultures were obtained (20.7 percent) from 44 447 samples taken. Gram negative bacteria were reported in 78.8 percent, Gram-positive in 13.8 percent and yeasts in 7.4 percent. Escherichia coli was the most frequently isolated bacterium (41.3 percent); antimicrobial resistance was higher in nosocomial isolates than in community strains (amikacin 92.4 vs. 97 percent, ceftazidime 83.1 vs. 95.1 percent and ciprofloxacin 46.2 vs. 58.6 percent). Pseudomonas aeruginosa showed a greater resistance to amikacin and ceftazidime in nosocomial cultures compared to community-acquired bacterial cultures (55.7 vs. 66.6 percent and 65.5 vs. 84.8 percent respectively). Vancomycin-resistant enterococci were found in only 2.5 percent (3 of 119 E. faecium isolates). CONCLUSIONS: Higher bacterial resistance was observed in nosocomial cultures than in community ones. Antimicrobial resistance was found to be progressively increasing for E. coli, the most frequent pathogen isolated both in nosocomial and community infections. We consider imperative the establishment of an intense educational campaign for the use and control of antibiotics.


Subject(s)
Humans , Cancer Care Facilities/statistics & numerical data , Drug Resistance, Bacterial , Drug Resistance, Fungal , Neoplasms/urine , Urine/microbiology , Bacteria/drug effects , Bacteria/isolation & purification , Bacterial Infections/epidemiology , Bacterial Infections/microbiology , Bacterial Infections/urine , Candida/drug effects , Candida/isolation & purification , Candidiasis/epidemiology , Candidiasis/microbiology , Candidiasis/urine , Community-Acquired Infections/epidemiology , Community-Acquired Infections/microbiology , Community-Acquired Infections/urine , Cross Infection/epidemiology , Cross Infection/microbiology , Cross Infection/urine , Enterococcus faecium/drug effects , Enterococcus faecium/isolation & purification , Mexico/epidemiology , Neoplasms/epidemiology , Neoplasms/microbiology , Retrospective Studies , Urinary Tract Infections/epidemiology , Urinary Tract Infections/microbiology , Urinary Tract Infections/urine
20.
Braz. j. infect. dis ; 11(2): 297-299, Apr. 2007.
Article in English | LILACS | ID: lil-454733

ABSTRACT

Enterococci are an uncommon cause of CNS infection. A 20 month-old boy, diagnosed with hydrocephalus with ventriculoperitoneal shunt and history of lengthy hospitalization and use of wide spectrum antibiotics, was admitted to the pediatric intensive care unit diagnosed with ventriculitis. On the 14th day of empirical antibiotic therapy (vancomycin and meropenem) the child presented fever while the CSF sample culture evidenced vancomycin-resistant Enterococcus faecium. The patient received intravenous linezolid achieving cerebrospinal fluid sterilization. Conclusion: Intravenous linezolid appears to be a safe and effective therapy for vancomycin-resistant enterococcus ventriculoperitoneal shunt infection.


Subject(s)
Humans , Infant , Male , Acetamides/therapeutic use , Anti-Infective Agents/therapeutic use , Cerebral Ventricles/microbiology , Encephalitis/drug therapy , Enterococcus faecium/isolation & purification , Gram-Positive Bacterial Infections/drug therapy , Oxazolidinones/therapeutic use , Vancomycin Resistance , Encephalitis/microbiology , Enterococcus faecium/drug effects , Gram-Positive Bacterial Infections/microbiology , Hydrocephalus/drug therapy , Hydrocephalus/microbiology , Treatment Outcome , Ventriculoperitoneal Shunt
SELECTION OF CITATIONS
SEARCH DETAIL